Phase I Open-Label Randomized Multicenter Study of XNW28012 Monotherapy in Metastatic Pancreatic Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Metastatic Pancreatic Cancer
Related studies linked through entity extraction aliases.
Study Evaluating the Safety Feasibility and Efficacy of ODI-2001 Vaccine, a Personnalized Immunotherapy in Patients With Metastatic or Locally Advanced Colon Cancer or Pancreatic Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Phase III Study to Compare GFH375 and Chemotherapy in Patients With KRAS G12D-Mutant Metastatic Pancreatic Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Early Treatment ctDNA Dynamics to Predict Response to Chemotherapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Phase II Study to Evaluate GFH375 in Patients With KRAS G12D Mutant Metastatic Pancreatic Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Multimodal Managements for Metastatic Pancreatic Cancer.
- Status
- COMPLETED
- Phase
- N/A
QL1706 Plus Chidamide, AG as First-line Treatment for Metastatic Pancreatic Cancer
- Status
- RECRUITING
- Phase
- PHASE2
The Effect of Kinisoquin™ on Thromboembolic Events in Patients With Metastatic or Locally Advanced Pancreatic Cancer
- Status
- RECRUITING
- Phase
- PHASE3
The Miami "EMPIRE" Trial - Eradication of Metastatic Pancreatic Cancer With Immuno-Radiation
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Evofosfamide in Combination with Zalifrelimab and Balstilimab
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
mFOLFIRINOX Plus Anlotinib and Sintilimab for Advanced Pancreatic Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Alpha Radiation Emitters (DaRT) With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer
- Status
- RECRUITING
- Phase
- NA
A Multi-center, Single-arm, Prospective Non-interventional Study to Investigate the Safety Profiles and Effectiveness of Liposomal Irinotecan (ONIVYDE®) in Combination with 5-fluorouracil (5-FU) and Leucovorin (LV) in Chinese Patients with Metastatic Pancreatic Cancer As Approval Condition (SEOPAC)
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
YL-13027 and/or HY-0102 Combined With AG Regimen Chemotherapy for Metastatic Pancreatic Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Anlotinib Plus Benmelstobart and AG in First-line Treatment of Advanced Metastatic Pancreatic Cancer (ALTER-PA-001)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Certepetide Phase 1b/2a Continuous Infusion Trial in mPDAC
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
An Open-label, Uncontrolled Study of ONO-4578 and ONO-4538 in Combination With Standard-of-care Modified FOLFIRINOX (mFFX) or Gemcitabine Plus Nab-paclitaxel (GnP) Therapy as First-line Treatment in Patients With Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 1 Trial of ERX-315 in Participants With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
An Open-label, Uncontrolled Study of ONO-7913 and ONO-4538 in Combination With Modified FOLFIRINOX Therapy, the Standard of Care, as First-line Treatment in Patients With Metastatic Pancreatic Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1